N1-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives were design, synthesized and tested for their in vitro antimycobacterial activity. The new compounds showed a moderate antimycobacterial activity against the tested strain of Mycobacterium tuberculosis H37Ra and a significant antimycobacterial activity against several mycobacteria other than tuberculosis strains.
Antimycobacterial activity of new N1-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives
ZAMPIERI, DANIELE;MAMOLO, MARIA GRAZIA;VIO, LUCIANO;ROMANO, MAURIZIO;
2016-01-01
Abstract
N1-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives were design, synthesized and tested for their in vitro antimycobacterial activity. The new compounds showed a moderate antimycobacterial activity against the tested strain of Mycobacterium tuberculosis H37Ra and a significant antimycobacterial activity against several mycobacteria other than tuberculosis strains.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
BMCL-2016.pdf
Accesso chiuso
Descrizione: Main text
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright Editore
Dimensione
309.96 kB
Formato
Adobe PDF
|
309.96 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
|
Supplementary information -DZ-rev2.pdf
Accesso chiuso
Descrizione: Supplementary information
Tipologia:
Altro materiale allegato
Licenza:
Copyright Editore
Dimensione
346.55 kB
Formato
Adobe PDF
|
346.55 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
